Mobile Menu - OpenMobile Menu - Closed

Hearing on "The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances"

Date: 
Thursday, December 2, 2021 - 10:30am
Location: 
Hybrid Hearing in the John D. Dingell Room, 2123 of the Rayburn House Office Building, and Cisco Webex

The Subcommittee on Health of the Committee on Energy and Commerce held a hybrid hearing that included both in-person and remote attendance on Thursday, December 2, 2021, at 10:30 a.m. This hearing took place in the John D. Dingell Room, 2123 of the Rayburn House Office Building, as well as remotely using Cisco Webex online video conferencing. The hearing is entitled, "The Overdose Crisis: Interagency Proposal to Combat Illicit Fentanyl-Related Substances."

 

Key Documents

Memorandum from Chairman Pallone to the Subcommittee on Health

Opening Statement from Chairman Pallone as prepared for delivery

Opening Statement from Subcommittee Chairwoman Eshoo as prepared for delivery

 

Livestream

 

Witnesses

Kemp L. Chester
Assistant Director
Executive Office of the President
Office of National Drug Control Policy

Testimony


Louis J. Milione
Principal Deputy Administrator
U.S. Drug Enforcement Administration

Testimony 


Lisa O. Monaco
Deputy Attorney General
U.S. Department of Justice


Douglas Throckmorton, M.D.
Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research
U.S. Food and Drug Administration

Testimony


Nora D. Volkow, M.D.
Director, National Institute on Drug Abuse
National Institutes of Health

Testimony

 

Issues: